In a prelude to overhauling its regulatory oversight of genetic diagnostic testing, the U.S. Food and Drug Administration will convene a public meeting next week to gather input from test makers and others.
SOURCE
Related Articles Read More >
Synchron’s plan to beat Neuralink in the neuroprosthetic BCI race
These devices are the top targets of lawsuit-related advertisements
Medical nitinol processing: How NiTi is turned into wire, tubes and sheets for medical devices
